Russian pharma pipeline dominated by private entities, but no clear source of capital
In the wake of Russia’s invasion of Ukraine, there have been significant financial sanctions on the country, crippling the Russian…
ByRussia
Latest in
Russia
An ethical dilemma: Should companies still sell essential products in Russia?
Is it ethical to sell baby food in Russia in an era of sanctions? Or medicine? This is a dilemma…
By
Will Russia’s invasion affect biopharmaceutical licensing agreements?
Western sanctions may make companies cautious about entering any strategic alliances with or receiving any capital from Russia.
By
Sanctions hit Russian investors with limited impact on foreign innovator drugs
Overall venture capital financing from US investors for foreign innovator drugs is almost 500 times that from Russian investors.
By
Clinical trials in Russia: big pharma makes moves but what’s the pipeline impact?
Certain big pharma companies have reconsidered their clinical trial footprint in Russia in response to the Ukraine invasion. Clinical Trials…
By
WHO delays Russia’s Sputnik V vaccine review amid Ukraine crisis
The Ukraine crisis had impacted assessments of the vaccine and the health agency was experiencing operational issues.
Lilly suspends investments in Russia amid Ukraine crisis
The company will donate profits generated from medicine sales in Russia to organisations that provide humanitarian relief.
Pfizer plans to halt additional investments in Russia amid Ukraine crisis
The company does not anticipate any supply chain disruptions or price pressure due to the Russia-Ukraine crisis.